Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.47
-0.08-3.14%
Last update: Oct 6, 4:04 PM
$2.47
-0.08-3.14%
Veru Inc (VERU) Stock Price, Quote, News & History
VERUNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Veru (NASDAQ:VERU) through any online brokerage.
Other companies in Veru’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Veru has a consensus price target of $29.50.
The stock price for Veru (NASDAQ: VERU) is $2.47 last updated October 6, 2026 at 4:04 PM EDT.
There are no upcoming dividends for Veru.
Veru does not have any upcoming earnings scheduled.
There is no upcoming split for Veru.
Veru is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
